The supression of p-P70S6K and p-S6 but not p-AKT S473 to their total proteins by rapamycin indirectly confirmed that it mainly inhibited mTORC1 rather than mTORC2 in the early phase of cirrhotic portal hypertension. This evidence concerns the gene RPS6 and liver disorder.